Article info
Editorial
Selective tumour necrosis factor receptor-1 inhibition in acute lung injury: a new hope or a false dawn?
- Correspondence to Dr Pratik Sinha, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA; pratik.sinha{at}ucsf.edu
Citation
Selective tumour necrosis factor receptor-1 inhibition in acute lung injury: a new hope or a false dawn?
Publication history
- Accepted March 5, 2018
- First published March 22, 2018.
Online issue publication
July 13, 2018
Article Versions
- Previous version (22 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.